PIM
IMMU

Partner Investment Management’s Immunomedics Inc IMMU Stock Holding History

Partner Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$230K Buy
+10,880
New +$192K 1.65% 26

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Partner Investment Management's IMMU Position: Q4 2019 in Review

Partner Investment Management opened a new position in Immunomedics Inc (IMMU) in Q4 2019: 10,880 shares worth $230K. The stake represents 1.65% of the portfolio and ranks #26 among its holdings.

245 funds tracked by Wall St. Rank hold IMMU as of Q4 2019.

  • Partner Investment Management held 10,880 shares of Immunomedics Inc worth $230K as of Q4 2019.
  • Immunomedics Inc was a new Partner Investment Management position in Q4 2019.
  • Immunomedics Inc made up 1.65% of Partner Investment Management's portfolio in Q4 2019, its #26 holding.
  • 245 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.